Category Archives: 2017

European Association for Clinical Pharmacology + Therapeutics.

Updates from the European Medicines Agency re Covid-19: advice to continue use of ACE inhibitors and ARBs… https://t.co/PM7SydbmId
March 27, 2020, 9:07 pm
RT @cpontesg: Median capitalized research and development investment to bring a new drug to market was estimated at $985.3 million (95% CI,…
March 5, 2020, 9:04 am
RT @ISSX: Don't miss these upcoming deadlines for #ISSX/EACPT2020! - #ISSXAwards Nominations Due February 28. Abstracts Due March 1. Early…
February 24, 2020, 8:11 pm
RT @PRandP_Journal: We are hiring a new Deputy Editor! Working alongside the Editor-in-Chief you will be responsible for reviewing and adap…
February 6, 2020, 10:23 pm

The EACPT blog provides news about our organization since 2012.

Updates from the European Medicines Agency re Covid-19: advice to continue use of ACE inhibitors and ARBs

27.3.20: Briefing from the European Medicines AgencyEMA reports that it is aware of recent media reports and publications which question […]
Updates from the European Medicines Agency: from vaccines to repurposing medicines and pharmacovigilance

24th-25th SeptemberThe European Medicines Agency has hosted its first meetings in Amsterdam for its Healthcare Professional Working Party […]
Hear from Prof Harry Sokol why gut microbiota are so important for human diseases and their treatments

The 14th EACPT Congress was held from 29th June to 2nd July in 2019 in Stockholm as a partnership between the EACPT and the Swedish Society for […]